Sonova Holding AG (SONVY)
57.13
+1.09
(+1.94%)
USD |
OTCM |
May 02, 16:00
Sonova Price: 57.13 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 56.60 | 57.27 | 56.60 | 57.13 | 11687.00 |
May 01, 2024 | 55.17 | 56.05 | 54.99 | 56.04 | 6315.00 |
Apr 30, 2024 | 55.76 | 55.88 | 55.42 | 55.42 | 12262.00 |
Apr 29, 2024 | 56.53 | 56.81 | 56.53 | 56.80 | 13322.00 |
Apr 26, 2024 | 56.11 | 56.49 | 56.08 | 56.35 | 10957.00 |
Apr 25, 2024 | 54.75 | 55.42 | 54.75 | 55.28 | 13429.00 |
Apr 24, 2024 | 56.05 | 56.05 | 55.73 | 55.91 | 10053.00 |
Apr 23, 2024 | 55.53 | 56.01 | 55.53 | 55.85 | 24433.00 |
Apr 22, 2024 | 55.24 | 55.91 | 55.24 | 55.76 | 11237.00 |
Apr 19, 2024 | 54.66 | 54.66 | 54.27 | 54.28 | 9097.00 |
Apr 18, 2024 | 54.20 | 54.52 | 54.18 | 54.23 | 10882.00 |
Apr 17, 2024 | 54.83 | 54.88 | 54.55 | 54.61 | 10216.00 |
Apr 16, 2024 | 55.23 | 55.62 | 55.05 | 55.46 | 16878.00 |
Apr 15, 2024 | 56.63 | 56.63 | 55.84 | 55.84 | 14374.00 |
Apr 12, 2024 | 56.28 | 56.40 | 55.80 | 55.83 | 4828.00 |
Apr 11, 2024 | 56.83 | 57.10 | 56.32 | 57.07 | 18312.00 |
Apr 10, 2024 | 56.32 | 56.38 | 55.92 | 55.95 | 10858.00 |
Apr 09, 2024 | 56.78 | 57.12 | 56.77 | 57.05 | 28178.00 |
Apr 08, 2024 | 56.32 | 56.82 | 56.32 | 56.63 | 10055.00 |
Apr 05, 2024 | 55.50 | 56.08 | 55.50 | 55.94 | 11632.00 |
Apr 04, 2024 | 56.35 | 56.44 | 55.74 | 55.87 | 12531.00 |
Apr 03, 2024 | 56.00 | 56.67 | 56.00 | 56.53 | 9638.00 |
Apr 02, 2024 | 55.86 | 56.01 | 55.63 | 55.94 | 19393.00 |
Apr 01, 2024 | 57.38 | 57.75 | 57.22 | 57.52 | 14261.00 |
Mar 28, 2024 | 57.66 | 58.03 | 57.64 | 57.95 | 15019.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
29.48
Minimum
Mar 23 2020
87.61
Maximum
Nov 04 2021
56.06
Average
52.33
Median
Jun 07 2023
Price Benchmarks
AC Immune SA | 2.42 |
CRISPR Therapeutics AG | 55.10 |
Addex Therapeutics Ltd | 8.85 |
NLS Pharmaceutics Ltd | 0.136 |
Molecular Partners AG | 3.765 |
Price Related Metrics
PS Ratio | 4.242 |
Price to Book Value | 7.384 |
Price to Free Cash Flow | 26.17 |
Earnings Yield | 3.87% |
Market Cap | 17.03B |
Operating PE Ratio | 22.50 |
Normalized PE Ratio | 25.86 |